XML 71 R59.htm IDEA: XBRL DOCUMENT v3.25.1
Supplemental Equity and Comprehensive Income Information - Changes in Equity (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Increase (decrease) in equity    
Balance at the beginning of the period $ 3,894 $ 4,868
Net income [1] 1,122 933
Other comprehensive income (loss), net of tax:    
Other comprehensive income (loss), net of tax 200 (47)
Dividends declared (396) (835)
Purchase of non-controlling interest 1  
Stock-based compensation 72 17
Reacquired stock (1,275) (21)
Issuances pursuant to stock option and benefit plans 905 18
Balance at the end of the period 4,523 4,933
Common stock and additional paid-in capital    
Increase (decrease) in equity    
Balance at the beginning of the period 7,238 6,965
Other comprehensive income (loss), net of tax:    
Stock-based compensation 72 17
Balance at the end of the period 7,310 6,982
Retained earnings    
Increase (decrease) in equity    
Balance at the beginning of the period 36,797 37,479
Net income 1,116 928
Other comprehensive income (loss), net of tax:    
Dividends declared (396) (835)
Issuances pursuant to stock option and benefit plans (85) (100)
Balance at the end of the period 37,432 37,472
Treasury stock    
Increase (decrease) in equity    
Balance at the beginning of the period (34,462) (32,859)
Other comprehensive income (loss), net of tax:    
Reacquired stock (1,275) (21)
Issuances pursuant to stock option and benefit plans 990 118
Balance at the end of the period (34,747) (32,762)
Accumulated other comprehensive income (loss)    
Increase (decrease) in equity    
Balance at the beginning of the period (5,731) (6,778)
Other comprehensive income (loss), net of tax:    
Other comprehensive income (loss), net of tax 200 (48)
Balance at the end of the period (5,531) (6,826)
Non-controlling interest    
Increase (decrease) in equity    
Balance at the beginning of the period 52 61
Net income 6 5
Other comprehensive income (loss), net of tax:    
Other comprehensive income (loss), net of tax 0 1
Purchase of non-controlling interest 1  
Balance at the end of the period $ 59 $ 67
[1] The Consolidated Statements of Cash Flows include the results of continuing and discontinued operations and, therefore, also include cash and cash equivalents associated with Solventum through its April 2024 separation from 3M that were presented in current assets of discontinued operations in the 3M Consolidated Balance Sheet.